"If cancer has impacted your life, it’s important to have caring, compassionate, knowledgeable medical professionals standing by to help you battle the illness. In Anchorage and the surrounding area, people turn to Alaska Oncology and Hematology, LLC for expert care and encouragement when they need it. The physicians at this local practice offer a wide range of effective, state-of-the-art cancer treatment options in a warm, supportive environment. The team at this local oncology office knows how often people experience an extensive range of emotions when faced with cancer. To help navigate the process, they provide patients and their families with useful information about understanding the disease and its symptoms."

During the past decade, Alaska Oncology and Hematology LLC conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 44 clinical trials were completed, i.e. on average, 31% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 33 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alaska Oncology and Hematology LLC" #1 sponsor was "National Cancer Institute (NCI)" with 77 trials, followed by "Alliance for Clinical Trials in Oncology" with 34 trials sponsored, "SWOG Cancer Research Network" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Gilead Sciences" with 15 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alaska Oncology and Hematology LLC" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Alaska Oncology and Hematology LLC" are "Invasive Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (6 trials). Many other conditions were trialed in "Alaska Oncology and Hematology LLC" in a lesser frequency.

Most popular intervention types in "Alaska Oncology and Hematology LLC" are "Drug" (156 trials), "Other" (92 trials), "Biological" (76 trials), "Procedure" (52 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (41 trials), "Computed Tomography" (30 trials), "Biospecimen Collection" (29 trials) and "Questionnaire Administration" (29 trials). Other intervention names were less common.

The vast majority of trials in "Alaska Oncology and Hematology LLC" are 164 trials for "All" genders, 22 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Alaska Oncology and Hematology LLC". undefined are not yet recruiting, 72 are recruiting, 83 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Alaska Oncology and Hematology LLC, 5 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Alaska Oncology and Hematology LLC, 5 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".